Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nurix Therapeutics (NRIX) Return on Invested Capital (2020 - 2021)

Historic Return on Invested Capital for Nurix Therapeutics (NRIX) over the last 5 years, with Q4 2025 value amounting to 0.63%.

  • Nurix Therapeutics' Return on Invested Capital fell 1600.0% to 0.63% in Q4 2025 from the same period last year, while for Nov 2025 it was 0.63%, marking a year-over-year decrease of 1600.0%. This contributed to the annual value of 0.54% for FY2025, which is 500.0% up from last year.
  • As of Q4 2025, Nurix Therapeutics' Return on Invested Capital stood at 0.63%, which was down 1600.0% from 0.65% recorded in Q3 2025.
  • Nurix Therapeutics' 5-year Return on Invested Capital high stood at 0.2% for Q1 2021, and its period low was 0.85% during Q1 2024.
  • In the last 4 years, Nurix Therapeutics' Return on Invested Capital had a median value of 0.5% in 2025 and averaged 0.49%.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first tumbled by -3100bps in 2022, then skyrocketed by 3900bps in 2025.
  • Quarter analysis of 4 years shows Nurix Therapeutics' Return on Invested Capital stood at 0.33% in 2021, then tumbled by -73bps to 0.57% in 2022, then increased by 17bps to 0.47% in 2024, then plummeted by -33bps to 0.63% in 2025.
  • Its last three reported values are 0.63% in Q4 2025, 0.65% for Q3 2025, and 0.5% during Q2 2025.